FDA Proposes Risk-Based Clinical Decision Support Software Rules
- The Food and Drug Administration (FDA) has released revised draft guidance on how it proposes to regulate clinical decision support software, after facing industry criticism of its 2017 draft guidance. The FDA is focusing on a risk-based approach to clinical decision support (CDS) software based on the risk to patients if the software...
